A study on immune-related adverse events in early phase clinical trials

A study on immune-related adverse events in early phase clinical trials - A study on immune-related adverse events in early phase clinical trials

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049431

Enrollment

800

Registered

2022-11-04

Start date

2022-09-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with individual consent for "Research on Collection and Storage of Clinical Specimens in Early Clinical Trials (for Future Exploratory Studies) (Research Project No. 2017-475)" who have blood and tissue specimens available for use

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
To verify the usefulness and validity of comprehensive analysis of cytokines, immune cells, etc. in early clinical trials.	—

Countries

Japan

Contacts

Public ContactYuki Katsuya

National Cancer Center Hospital Department of experimental development

ykatsuya@ncc.go.jp0335422511

Outcome results